Breaking News, Promotions & Moves

ADC Therapeutics Names CEO

Industry veteran Chris Martin to lead the company

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. Chris Martin has been appointed chief executive officer, ADC Therapeutics Sarl. Dr. Martin was co-founder of Spirogen Ltd. and its chief executive officer leading up to the sale of Spirogen to MedImmune, in 2013. Dr. Martin became both a member of Medimmune’s management leadership team and AstraZeneca’s senior leaders group. Dr. Martin continues to advise Medimmune as a consultant.   Dr. Martin played an important role in the formation of ADC Therapeutics in 2012, and has served on its board...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters